Powered by: Motilal Oswal
2026-07-18 12:45:45 pm | Source: Emkay Global Financial Services Ltd
Reduce WiproLtd for the Target 170 by Emkay Global Financial Services Ltd
Reduce  WiproLtd for the Target 170 by Emkay Global Financial Services Ltd

Wipro logged a weak revenue performance in 1Q, on delayed ramp-ups of previously won large deals, continued weakness in select BFSI and Healthcare accounts, and elongated client decision cycles amid a challenging macro environment. IT Services revenue declined 1.4% qoq to $2.6bn (-1.2% CC), in line with our estimates. IT Services EBITM declined 130bps sequentially to 16.0%. Deal intake stood at ~$3.4bn in 1Q (including 13 large-deal bookings worth ~$1.6bn in total), with a book-to-bill of 1.3x. A few deal decisions have slipped into 2Q, while the pipeline continues to remain robust. Per management, traditional cost-optimization and vendor-consolidation deals remain competitively priced, with AI-led productivity commitments embedded upfront, while net-new AI transformation, advisory, and data modernization engagements support premium pricing and higher margins. It guided for -1.5% to 0.5% qoq CC revenue growth in 2Q, lower than our estimate. It aspires to maintain margins in a narrow 17-17.5% band over the medium term through automation, AI-led productivity, operational efficiencies, and pyramid optimization, while continuing to prioritize strategic AI investments. We tweak our FY27E EPS by ~0.6% and largely retain FY28/29E EPS, after factoring in the 1Q performance. We lower TM to 12x, considering continued weakness in organic revenue growth. We retain REDUCE and cut TP by 15% to Rs170 (from Rs200 earlier) at 12x Jun-28E EPS.

Results summary

Wipro reported revenue of $2.6bn, down 1.4% qoq (-1.2% qoq CC), in line with our expectations. IT Services EBITM declined 130bps qoq to 16.0%, vs our estimate of 16.6%, driven by salary increase, ramp-up of earlier large deals, and ongoing AI investments, partially offset by rupee depreciation and operational efficiencies. Overall EBITM declined 130bps qoq to 16.0%. The company signed large deals with TCV of $1.6bn. Overall order booking stood at $3.4bn (book-to-bill of ~1.3x). Total headcount was up 0.4% qoq at 243,044. Attrition (TTM IT services excluding BPS) increased 10bps qoq to 13.9%. Wipro declared an interim dividend of Rs2/share. What we like: Healthy deal intake. What we do not like: Margin miss, softness in BFSI, Healthcare, and EMR.

Broad-based weakness across verticals, partly offset by Consumer and Tech

The decline in revenue growth was led by Financial Services (-1.2% qoq CC), Healthcare (-2.6%), and EMR (-3.6%), partially offset by growth in Consumer (0.7%) and Technology and Communications (0.2%). BFSI was impacted by delayed large-deal ramp-ups and slower client decision-making, while Healthcare remained impacted by sustained structural and demographic pressure in the US payer/provider ecosystem and evolving member-onboarding services.

Americas and Europe remained weak, with APMEA cushioning the impact

The company restated its Americas segments wef Apr-26, realigning LatAm/Canada customers and subsuming Hi-tech and Airports into Americas 1. Among strategic market units, APMEA grew 4.4% qoq CC, while Europe, Americas 1, and Americas 2 declined 0.9%, 2.3%, and 2.5%, respectively.

 

For More  Emkay Global Financial Services Ltd Disclaimer http://www.emkayglobal.com/Uploads/disclaimer.pdf & SEBI Registration number is INH000000354

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here